Disability Benefits for Alzheimer's Disease

How SSA Evaluates Alzheimer's Disease Under Listing 12.02

Alzheimer's disease is the most common cause of dementia, gradually eroding memory, thinking, and the ability to manage daily life. SSA evaluates it under Blue Book listing 12.02 for neurocognitive disorders, which has two parts that must both be satisfied.

The Two-Part Test

First, the medical evidence must show a significant decline in one or more areas of thinking, such as memory, attention, language, planning, or judgment. Second, that decline must cause either an extreme limitation in one, or a marked limitation in two, of these areas of mental functioning:

• Understanding, remembering, or using information.
• Interacting with others.
• Concentrating, persisting, or keeping pace.
• Adapting or managing yourself — for example, handling everyday tasks, hygiene, and safety.

SSA can also approve under a second path (paragraph C) for serious, persistent disorders where ongoing treatment or a highly structured setting only marginally limits the effects of the disease. Because Alzheimer's is progressive, SSA looks at the overall course of the illness rather than a single visit. Importantly, early-onset (younger-onset) Alzheimer's disease is on SSA's Compassionate Allowances list, so those claims are flagged for expedited processing once the diagnosis is documented. Statements from family members and caregivers about day-to-day functioning carry real weight alongside the medical records.

Medical Evidence for an Alzheimer's Claim

Alzheimer's claims are strongest when they combine medical findings with real-world accounts of decline. SSA will look for:

• A physician's diagnosis, ideally from a neurologist, geriatric specialist, or memory clinic.
• Cognitive testing — mental status exams or neuropsychological testing measuring memory, language, and reasoning.
• Imaging or lab work used to support the diagnosis and rule out other causes.
• Function reports from family or caregivers describing problems with memory, decision-making, hygiene, and safety.

Ask the treating doctor to describe how the disease affects the person's ability to remember instructions, stay on task, interact appropriately, and manage daily activities safely. Because Alzheimer's reduces insight, statements from those who provide care are often the clearest evidence of how far the disease has progressed, and they help SSA see the full picture beyond a brief office visit.

Qualifying Through an RFC Assessment

When the medical evidence does not yet satisfy listing 12.02, SSA assesses residual functional capacity (RFC) for mental work. Alzheimer's undermines the core abilities that competitive work requires: remembering and following instructions, learning new tasks, concentrating, and keeping a reliable pace. Even in early stages, a person may forget procedures, lose track of steps, or need constant reminders.

As the disease advances, problems with judgment, orientation, and safety awareness make most jobs impossible, and getting lost or forgetting hazards can rule out work that involves travel or equipment. SSA translates these problems into a mental RFC and compares it to past work. Because Alzheimer's is progressive and the ability to learn and adapt is central to nearly all jobs, the limitations it causes often rule out sustained full-time work entirely, especially once memory and judgment are significantly affected.

Tips for a Stronger Alzheimer's Claim

• Ask about Compassionate Allowances. Early-onset Alzheimer's is on SSA's expedited list, so make sure the diagnosis and age of onset are clearly documented.
• Get cognitive testing. Neuropsychological testing gives objective proof of the decline SSA needs to see.
• Gather caregiver statements. Detailed accounts of daily problems with memory, safety, and self-care are powerful evidence.
• See a specialist. A neurologist or memory clinic makes the diagnosis and its severity more credible.
• Document safety concerns — wandering, leaving appliances on, or trouble managing money — since these show the real-world impact.